Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


T. Ueno, S. Uchiyama and N. Kikuchi, “The Role of Intestinal Bacteria on Biological Effects of Soy Isoflavones in Human,” Journal of Nutrition, Vol. 132, 2002, p. 594S.

has been cited by the following article:

  • TITLE: The Development of S-Equol Diastereoisomer Specific ELISA

    AUTHORS: Takayuki Minekawa, Akira Kambegawa, Kumiko Shindome, Shizuka Takehara, Hidetoshi Arakawa

    KEYWORDS: S-Equol; Diastereoisomer; Immunoassay; ELISA; Isoflavone; Deconjugation

    JOURNAL NAME: American Journal of Analytical Chemistry, Vol.3 No.6, June 21, 2012

    ABSTRACT: Equol is a metabolite of soybean isoflavone, daidzein, and many health benefits are expected. Endogenous equol in urine is S-equol and mostly exists as glucuronate or sulfate conjugate. In this study we preliminary established the simple enzyme-linked immunosorbent assay (ELISA) without deconjugation, then developed the S-equol specific ELISA involves deconjugation showing high stereospecificity to S-equol without using stereospecific antibody. For the simple ELISA, we used a polyclonal antibody that targets the regions not influenced by inhibition by conjugation of glucuronate and sulfate and achieved the correlation coefficient; r = 0.975, but the value was 30 % lower than high performance liquid chromatography (HPLC). Developing upon this we invented the specific ELISA established from S-equol homogeneous combination for the standard and enzyme-labeled antigen to enhance stereospecificity. The correlation with HPLC was favorable: r = 0.986, y = 0.996x – 6. Compared to the previous method using (R,S)-equol combination, cross-reactivity with R-equol was reduced from 65 to 13 %, and that with daidzein from 0.31% to 0.08%, markedly increased in the specificity. This study is expected to be applied for both simple clinical researches, and stereospecific immunoassays in which specific antibody preparation is difficult.